Hana Pharm Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Hana Pharm.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Pharmaceuticals earnings growth | 33.3% |
| Revenue growth rate | n/a |
| Future return on equity | n/a |
| Analyst coverage | None |
| Last updated | n/a |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2022 | 211,000 | 25,000 | N/A | 34,000 | 1 |
| 12/31/2017 | 139,331 | 24,305 | 13,959 | 25,380 | N/A |
| 12/31/2016 | 124,535 | 17,431 | 4,102 | 12,464 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if A293480's forecast earnings growth is above the savings rate (2.7%).
Earnings vs Market: Insufficient data to determine if A293480's earnings are forecast to grow faster than the KR market
High Growth Earnings: Insufficient data to determine if A293480's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if A293480's revenue is forecast to grow faster than the KR market.
High Growth Revenue: Insufficient data to determine if A293480's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if A293480's Return on Equity is forecast to be high in 3 years time